Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Am J Hematol. 2022 Feb 9;97(5):E166–E167. doi: 10.1002/ajh.26484

Transfusion-Dependent Anemia Secondary to Vitamin C Deficiency

Allison M Angeli 1, Bryant Megna 2, Marshall Mazepa 3, Zalaya K Ivy 3, Shahnaz Sultan 2, Joshua A Sloan 2
PMCID: PMC8986622  NIHMSID: NIHMS1776740  PMID: 35108411

Scurvy, or the syndrome of vitamin C deficiency, is rare in industrialized nations though is still seen in underserved populations and those with risk factors for severe malnutrition. It presents with fatigue, myalgias, arthralgias, skin and mucosal bleeding, perifollicular hemorrhage, gingivitis, and coiled body hair. Mild anemia occurs in many cases due to hemorrhage, hemolysis, impaired erythropoiesis, or associated folate deficiency.14 We present a case of scurvy manifesting with profound transfusion-dependent anemia.

A 57-year-old man presented to the emergency department due to symptomatic anemia (hemoglobin 5.7 g/dL). He noted two weeks of dyspnea on exertion, dizziness, arthralgias, myalgias, and easy bruising. Vitals were notable for hypotension at 72/54 mmHg. Physical exam demonstrated bilateral lower extremity edema, tenderness, and ecchymoses. Hemoglobin was 5.1 g/dL, and reticulocyte count was 0.15 mil/mm3 (0.03–0.08 mil/mm3). Elevated total bilirubin and lactate dehydrogenase were noted due to a known resolving quadriceps hematoma. Haptoglobin and DAT were normal. Normal PT (14.6 sec), aPTT (31 sec), and fibrinogen (322mg/dL) provided no evidence for coagulopathies. Vitamin B12 was deficient (129 pg/mL), and he received 1,000 mcg daily oral B12 replacement beginning on day 14, with no improvement in the anemia. The folate level was normal (4.7 ng/mL) and the mean corpuscular volume was normocytic (95 fL). As a result, homocysteine and methylmalonic acid were not tested. No source of bleeding was identified on colonoscopy, esophagogastroduodenoscopy, computed tomography (CT) of the chest/abdomen/pelvis, CT angiogram of the abdomen/pelvis/lower extremities, tagged red blood cell study, bilateral lower extremity CT, and right femur magnetic resonance imaging. Peripheral smear showed hypochromic, normocytic anemia. Bone marrow biopsy showed no dysplasia or blasts, intact trilineage hematopoiesis, hypocellular marrow (5–25%), and no gelatinous transformation.5 He required 20 units of packed red blood cell (pRBC) transfusions over the 26-day-long admission.

He was then transferred to a tertiary care center for further management. The vitamin B12 replacement was switched from oral to intramuscular 1,000 mcg daily for seven days, without improvement in pRBC transfusion requirements. A capsule endoscopy was unremarkable. Assessments for infections (HIV, EBV, CMV, parvovirus, HBV, HCV), coagulopathies (INR, aPTT, PT, fibrinogen), hemolysis (haptoglobin, lactate dehydrogenase, DAT), pernicious anemia (parietal cell antibodies), autoimmune processes (C3, C4, CH50, anti-Jo antibody, CRP, ESR), and factor deficiencies (factor 10 assay, factor 13 assay) were normal. The total bilirubin remained elevated at 2.0 mg/dL. A repeat peripheral blood smear and bone marrow biopsy were not significantly changed. He required 10 more units of pRBCs.

On day 28, the patient described months of a micronutrient-poor diet consisting universally of simple carbohydrates. Physical exam revealed persistent lower extremity edema and ecchymoses, subcutaneous hemorrhages, perifollicular changes, coiled body hair, and gingival erythema. Vitamin C levels were collected on days 29 and 31, which resulted as undetectable (< 5 umol/L) on day 32. Vitamin C supplementation was initiated at 250 mcg twice daily. Three days later, no further pRBC transfusions were needed, and after four days, the vitamin C level was 14 umol/L (LLN 23 umol/L). In one week, the hemoglobin was 9.1 g/dL and continued to rise to 15.9 g/dL at about five months later.

While anemia may occur in up to 80% of patients with scurvy, it is typically mild.2 There are case reports of it being transfusion-refractory and transfusion-dependent.6,7 Unlike these cases, our patient had no identifiable source of bleeding and required significantly more pRBC transfusions – nearly 30 units in a six-week period.

The mechanism of scurvy-associated anemia is multifactorial and may involve hemorrhage, hemolysis, impaired erythropoiesis, and folate deficiency.14 Vitamin C deficiency causes improper collagen synthesis, leading to impaired blood vessel wall integrity and subsequent extravasation of erythrocytes.23 Vitamins C, B9, and B12 are necessary for erythropoiesis. More specifically, the crosstalk of vitamin C with the enzyme isocitrate dehydrogenase 1 (IDH1) has been shown to regulate the final steps of erythropoiesis, during which vitamin C scavenges reactive oxygen species to rescue erythroid differentiation.8 Deficiency of vitamins B9 and B12 may occur in patients with scurvy due to insufficient dietary intake or due to vitamin C’s effects on their metabolism.14 Since vitamin C functions as an antioxidant to maintain erythrocyte membranes, vitamin C deficiency may lead to unopposed oxidant injury in erythrocytes and subsequent hemolysis.23, 910

In this patient, no hemorrhagic source was identified on extensive imaging and endoscopic evaluation, and the petechiae and ecchymoses incompletely explain the degree of anemia. There was no evidence for hemolysis, except for an indirect hyperbilirubinemia, which suggests a minimal role of hemolysis in this patient’s extreme anemia. The patient’s severe reticulocytopenia and transfusion dependence suggest that the primary etiology was severe impairment of erythropoiesis, despite normal bone marrow morphology. Replacement of vitamin B12 and normal folate levels did not restore reticulocytosis. Only when given high-dose vitamin C did reticulocytosis rapidly increase, transfusion dependence cease, and the anemia completely resolve.

In conclusion, scurvy is rare in industrialized nations and there is little literature on it presenting with transfusion-dependent anemia. The mechanism by which vitamin C deficiency leads to anemia is multifactorial and, as demonstrated in this case, incompletely understood. Further research is needed to understand the role of vitamin C deficiency in hemolysis and erythropoiesis.

Figure 1.

Figure 1.

Physical exam findings included (a) coiled or “corkscrew” body hair, and (b) bilateral lower extremity edema and ecchymoses.

Acknowledgments

Funding: NIH T32 Award 5T32HL007062-45 (Zalaya Ivy, MD PhD)

Footnotes

Disclosures: none

References

  • 1.Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol. 1999. Dec;41(6):895–906. [DOI] [PubMed] [Google Scholar]
  • 2.Cox EV. The Anemia of Scurvy. In: Harris RS, Wool IG, Loraine JA, Thimann KV (eds). Vitamins & hormones. Cambridge: Academic Press, 1969, pp 635–652. [DOI] [PubMed] [Google Scholar]
  • 3.Shaikh H, Faisal MS, Mewawalla P. Vitamin C deficiency: rare cause of severe anemia with hemolysis. Int J Hematol. 2019. May;109(5):618–621. [DOI] [PubMed] [Google Scholar]
  • 4.Alhatem A, Cai D. Behind the Skin: A Rare Case of Scurvy-Associated Megaloblastic Anemia. Clin Med Insights Case Rep. 2019. May 10;12:1179547619849036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brennan CM, Atkins KA, Druzgal CH, Gaskin CM. Magnetic resonance imaging appearance of scurvy with gelatinous bone marrow transformation. Skeletal Radiol. 2012;41(3):357–360. doi: 10.1007/s00256-011-1350-9 [DOI] [PubMed] [Google Scholar]
  • 6.Venkataraman V, Olson KR. Irritable bowel syndrome leading to scurvy from a severely restricted diet. Proc (Bayl Univ Med Cent). 2020. Jul 23;33(4):627–629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alten ED, Chaturvedi A, Cullimore M, Fallon AA, Habben L, Hughes I, O’Malley NT, Rahimi H, Renodin-Mead D, Schmidt BL, Weinberg GA, Weber DR. No longer a historical ailment: two cases of childhood scurvy with recommendations for bone health providers. Osteoporos Int. 2020. May;31(5):1001–1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gonzalez-Menendez P, Romano M, Yan H, et al. An IDH1-vitamin C crosstalk drives human erythroid development by inhibiting pro-oxidant mitochondrial metabolism. Cell Rep. 2021;34(5):108723. doi: 10.1016/j.celrep.2021.108723 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tu H, Li H, Wang Y, Niyyati M, Wang Y, Leshin J, Levine M. Low Red Blood Cell Vitamin C Concentrations Induce Red Blood Cell Fragility: A Link to Diabetes Via Glucose, Glucose Transporters, and Dehydroascorbic Acid. EBioMedicine. 2015. Oct 3;2(11):1735–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kuhn V, Diederich L, Keller TCS 4th, Kramer CM, Lückstädt W, Panknin C, Suvorava T, Isakson BE, Kelm M, Cortese-Krott MM. Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia. Antioxid Redox Signal. 2017. May 1;26(13):718–742. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES